Statistics
Publications
9
Citations
971
H-Index
9
Active since
2019
Julien Dilly is an author at Broad Institute specializing in oncology, molecular oncology, and medicine.
Publications per year
2019–2025
9
9
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 318 citations · Full text
Medicine, Oncology, Pharmacology +16
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T. Hoffman, Laleh Abbassi et al. · Cancer Discovery · 2024 · 234 citations · Full text
Medicine, Oncology, Pharmacology +17
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 175 citations · Full text
Medicine, Oncology, Pharmacology +17
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
Xinyuan Tong, Ayushi S. Patel, Eejung Kim et al. · Cancer Cell · 2024 · 115 citations · Full text
1–5 of 9